PubMed:15461822 / 1486-1626 JSONTXT

{"project":"LitCoin-entities","denotations":[{"id":"1123","span":{"begin":4,"end":9},"obj":"OrganismTaxon"},{"id":"1124","span":{"begin":9,"end":16},"obj":"SequenceVariant"},{"id":"1125","span":{"begin":21,"end":26},"obj":"OrganismTaxon"},{"id":"1126","span":{"begin":26,"end":38},"obj":"SequenceVariant"},{"id":"1127","span":{"begin":83,"end":89},"obj":"OrganismTaxon"},{"id":"1128","span":{"begin":125,"end":131},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A42","pred":"db_id","subj":"1123","obj":"NCBITaxon:11060"},{"id":"A43","pred":"db_id","subj":"1124","obj":"c|DEL||30"},{"id":"A44","pred":"db_id","subj":"1125","obj":"NCBITaxon:11060"},{"id":"A45","pred":"db_id","subj":"1126","obj":"c|DEL|4995|30"},{"id":"A46","pred":"db_id","subj":"1127","obj":"NCBITaxon:9606"},{"id":"A47","pred":"db_id","subj":"1128","obj":"MESH:D003715"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":140},"obj":"Sentence"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-entities-OrganismTaxon-PD","denotations":[{"id":"T24","span":{"begin":39,"end":46},"obj":"OrganismTaxon"},{"id":"T25","span":{"begin":83,"end":89},"obj":"OrganismTaxon"}],"attributes":[{"id":"A24","pred":"db_id","subj":"T24","obj":"NCBItxid:10239"},{"id":"A25","pred":"db_id","subj":"T25","obj":"NCBItxid:9605"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T8","span":{"begin":9,"end":16},"obj":"SequenceVariant"},{"id":"T9","span":{"begin":26,"end":38},"obj":"SequenceVariant"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T33","span":{"begin":108,"end":112},"obj":"GeneOrGeneProduct"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T5","span":{"begin":125,"end":131},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D003715"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T9","span":{"begin":47,"end":50},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0012833"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T9","span":{"begin":125,"end":131},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"D003715"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T10","span":{"begin":125,"end":139},"obj":"ChemicalEntity"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"D053059"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T25","span":{"begin":39,"end":46},"obj":"OrganismTaxon"},{"id":"T26","span":{"begin":83,"end":89},"obj":"OrganismTaxon"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T10","span":{"begin":125,"end":139},"obj":"ChemicalEntity"},{"id":"T26","span":{"begin":83,"end":89},"obj":"OrganismTaxon"},{"id":"T25","span":{"begin":39,"end":46},"obj":"OrganismTaxon"},{"id":"T68177","span":{"begin":26,"end":38},"obj":"SequenceVariant"},{"id":"T18835","span":{"begin":9,"end":16},"obj":"SequenceVariant"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"D053059"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"Inflammaging","denotations":[{"id":"T15","span":{"begin":0,"end":140},"obj":"Sentence"},{"id":"T15","span":{"begin":0,"end":140},"obj":"Sentence"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}

{"project":"tmVarCorpus","denotations":[{"id":"T8","span":{"begin":9,"end":16},"obj":"DNAMutation:|DEL||30"},{"id":"T9","span":{"begin":26,"end":33},"obj":"DNAMutation:|DEL||30"}],"text":"The rDEN2Delta30 and rDEN2Delta30-4995 viruses can be considered for evaluation in humans and for inclusion in a tetravalent dengue vaccine."}